Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Sees Significant Growth in Short Interest

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 28,100 shares, an increase of 5.2% from the November 15th total of 26,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Basilea Pharmaceutica Stock Up 3.1 %

BPMUF opened at $52.83 on Monday. Basilea Pharmaceutica has a twelve month low of $38.60 and a twelve month high of $52.83. The company has a 50-day simple moving average of $52.70 and a 200 day simple moving average of $50.34.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright raised shares of Basilea Pharmaceutica to a “strong-buy” rating in a report on Monday, September 23rd.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.